drugset / Trial / NCT00601367
Flibanserin Evaluation Over 28 Additional Weeks in Hypoactive Sexual Desire Disorder
NaSingle-groupOpen-labelTreatment
Summary
Safety profile of flibanserin over 28 additional weeks Distribution of preferred dose regimens
Timeline
- Start
- 2008-01
- Primary completion
- 2009-10
- Completion
- 2009-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | flibanserin | Small molecule | 50 mg | — |
| Subject | flibanserin | Small molecule | 100 mg | — |